Antimicrobial

Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins

Inbiome, developing a new PCR technology capable of simultaneous identification of hundreds of bacterial pathogens in a single test, welcomes Professor Dr. Carl Wittwer to its Advisory Board

Prof. Carl Wittwer Appointed in inbiome's Advisory Board Amsterdam, The Netherlands, September 20, 2024. Inbiome, a pioneer in advanced molecular diagnostics,...

Basilea enters into agreement with BARDA to develop novel antifungals and antibacterials and receives initial funding

Initial funding of USD 29 million to support development of Basilea’s clinical stage first-in-class antifungals, fosmanogepix and BAL2062Multi-year Other Transaction...

Verily Sightline Expands Wastewater Testing Services to Europe Through Partnership with Bangor University in Wales

Exclusive partnership brings Verily’s innovative wastewater surveillance technology to the United Kingdom DALLAS--(BUSINESS WIRE)--Today, Verily, a precision health technology company,...

F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US

Financing is being led by new investor AMR Action Fund with strong participation from new investor ICG Life Sciences and...

error: Content is protected !!